• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A34-34/C80-O20
Device Problems Leak/Splash (1354); Material Puncture/Hole (1504); Product Quality Problem (1506); Stretched (1601); Material Integrity Problem (2978); Unintended Movement (3026); Migration (4003)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 10/19/2018
Event Type  Injury  
Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.If additional information is obtained at a later time that is pertinent to this event, a follow-up report will then be submitted.
 
Event Description
The patient was initially treated with the afx abdominal aortic aneurysm stent.Approximately three (3) years post initial procedure, an aneurysm enlargement (to 7.5cm) and type iiib endoleaks of the cuff and main body with minimal overlap between the two (2) devices were detected during routine follow-up cta.The physician will continue to monitor the patient who is reportedly doing well.There have been no additional patient sequelae reported.
 
Manufacturer Narrative
At the completion of the clinical evaluation and based on the information received, there was substantial evidence to support the reported events of the type iiib endoleak (and stent cage dilation) of the proximal extension device.The complaint is most likely device-related due to strata material, in combination with heavy calcifications at the neck and iliacs (cautionary).Procedure-related harms could not be determined, and the final patient status was reported to be doing well.The manufacturing lot review confirmed all devices met specifications prior to release.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.A root cause investigation was carried out for all afx complaints having an identified failure mode of a type iiib endoleak.Endologix implemented the following corrective actions with the intent of reducing type iiib endoleak events; 1.Upgraded graft material (i.E.Duraply) and 2.Updates to the ifu and additional physician training.The change to duraply graft material and the ifu changes were put in place july 2014.Device code - remove 1354.Conclusion code - remove 11.
 
Event Description
Additional information received confirming that the physician unsuccessfully attempted repair on (b)(6) 2019 due to the inability to gain access to the patient's right iliac artery.The physician attempted to treat with a perclose proglide (non-endologix) device which became stuck in the patient's vessel; patient was transitioned to a cut-down femoral artery procedure, and the device was successfully removed.The final angiogram showed no endoleak, but there was presence of proximal extension migration and minimal overlap between the bifurcated and proximal extension devices.The patient tolerated the procedure well.In addition, clinical assessment confirmed that stent cage dilation of the proximal extension was also present.This report is only for the suprarenal aortic (proximal) extension.Please refer to mfr.Report # 2031527-2018-00859 for report to the bifurcated stent graft.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key8057559
MDR Text Key126901438
Report Number2031527-2018-00851
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Remedial Action Recall
Type of Report Initial,Followup
Report Date 10/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2015
Device Model NumberA34-34/C80-O20
Device Lot Number1025847-046
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/19/2018
Initial Date FDA Received11/09/2018
Supplement Dates Manufacturer Received10/19/2018
Supplement Dates FDA Received02/21/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0008-2019
Patient Sequence Number1
Treatment
AFX-BIFURCATED STENT GRAFT: 1047120-016
Patient Outcome(s) Other;
Patient Age82 YR
-
-